No. I'll re-word it for you since it's a point of contention.
@Mason14 If you have time can you take a look at the clinical trials and share your thoughts positive or negative on the science like you have done with other companies. Thank you.
Ann: Primary Endpoint Achieved in Phase 2 MPS VI Trial, page-64
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
28.5¢ |
Change
-0.005(1.72%) |
Mkt cap ! $101.4M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 29.0¢ | 28.5¢ | $29.03K | 100.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 14710 | 28.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.0¢ | 23170 | 7 |
View Market Depth
| Last trade - 11.29am 24/07/2024 (20 minute delay) ? |
| PAR (ASX) Chart |